Literature DB >> 28443490

Waiting times for cancer patients in Sweden: A nationwide population-based study.

Stephanie Robertson1,2, Jan Adolfsson3, Pär Stattin4,5, Annika Sjövall6,7, Rocio Winnersjö8, Marianne Hanning8, Kerstin Sandelin7,9.   

Abstract

AIMS: The reported long waiting times for cancer patients have mostly been related to prognostic outcome and less to patient-related experience to outcome. We assessed waiting times for patients with cancer of the breast, prostate, colon or rectum in Sweden.
METHODS: The median time from referral to start of treatment was assessed using data from clinical cancer registers for patients who received curative treatment during 2011, 2012 and 2013.
RESULTS: The median overall waiting time in different counties ranged from 7 to 28 days for breast cancer, from 117 to 280 days for prostate cancer, from 27 to 64 days for colon cancer and from 48 to 80 days for rectal cancer. For the entire nation, the median time from referral to start of treatment remained unchanged from 2011 to 2013 for each cancer diagnosis.
CONCLUSIONS: Large variations were found in waiting times between different counties in Sweden and between different types of cancer. The long waiting times identified in this study emphasize the need to improve national programmes for more rapid diagnosis and treatment.

Entities:  

Keywords:  Cancer care; breast cancer; colon cancer; prostate cancer; rectal cancer; waiting time

Mesh:

Year:  2017        PMID: 28443490     DOI: 10.1177/1403494817693695

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  7 in total

1.  Waiting Times for Prostate Cancer Diagnosis in a Nigerian Population.

Authors:  Olufunmilade A Omisanjo; Olawale O Ogunremi; Olufemi O Akinola; Olaolu O Adebayo; Olufemi Ojewuyi; Mofeyisayo O Omorinde; Abimbola A Abolarinwa; Stephen O Ikuerowo; Fatai A Balogun
Journal:  J Cancer Epidemiol       Date:  2021-08-16

2.  Rapid Histological Assessment of Prostate Specimens in the Three-dimensional Space by Hydrophilic Tissue Clearing and Confocal Microscopy.

Authors:  Yu-Ching Peng; Yu-Chieh Lin; Yu-Ling Hung; Chien-Chung Fu; Margaret Dah-Tsyr Chang; Yen-Yin Lin; Teh-Ying Chou
Journal:  J Histochem Cytochem       Date:  2022-07-30       Impact factor: 4.137

3.  Implementing standardized cancer patient pathways (CPPs) - a qualitative study exploring the perspectives of health care professionals.

Authors:  Sara Delilovic; Henna Hasson; Mårten Åhström; Mia von Knorring
Journal:  BMC Health Serv Res       Date:  2019-08-16       Impact factor: 2.655

4.  Waiting times for prostate cancer: A review.

Authors:  Giacomo Lazzeri; Gianmarco Troiano; Barbara Rita Porchia; Federica Centauri; Vincenzo Mezzatesta; Giorgio Presicce; Daniela Matarrese; Roberto Gusinu
Journal:  J Public Health Res       Date:  2020-06-04

5.  Merging existing practices with new ones: the adjustment of organizational routines to using cancer patient pathways in primary healthcare.

Authors:  Petter Fjällström; Anna-Britt Coe; Mikael Lilja; Senada Hajdarevic
Journal:  BMC Health Serv Res       Date:  2022-01-02       Impact factor: 2.655

6.  Exploring wait time variations in a prostate cancer patient pathway-A qualitative study.

Authors:  Anne Grete Valbekmo; Lise Mo; Gudveig Gjøsund; Erna Håland; Line Melby
Journal:  Int J Health Plann Manage       Date:  2022-03-28

7.  Results of the IROCA international clinical audit in prostate cancer radiotherapy at six comprehensive cancer centres.

Authors:  Carla Lopes de Castro; Magdalena Fundowicz; Alvar Roselló; Josep Jové; Letizia Deantonio; Artur Aguiar; Carla Pisani; Salvador Villà; Anna Boladeras; Ewelina Konstanty; Marta Kruszyna-Mochalska; Piotr Milecki; Diego Jurado-Bruggeman; Joana Lencart; Ignasi Modolell; Carles Muñoz-Montplet; Luisa Aliste; Maria Gloria Torras; Montserrat Puigdemont; Luísa Carvalho; Marco Krengli; Ferran Guedea; Julian Malicki
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.